Literature DB >> 20953904

Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study.

Emily J Fearnley1, Louise Marquart, Amanda B Spurdle, Philip Weinstein, Penelope M Webb.   

Abstract

OBJECTIVE: Although polycystic ovary syndrome (PCOS) is commonly cited as a risk factor for endometrial cancer, supporting epidemiological evidence is currently very limited. Our aim was to assess the associations between PCOS, PCOS symptoms, and risk of endometrial cancer in women aged less than 50 years.
METHODS: Data came from a national population-based case-control study in Australia. Cases with newly diagnosed histologically confirmed endometrial cancer were identified through treatment clinics and cancer registries Australia wide. Controls were randomly selected from the national electoral roll. Women were interviewed about their reproductive and medical history, including self-reported PCOS, and lifestyle. Current analyses were restricted to women aged under 50 (156 cases, 398 controls). We estimated odds ratios (OR) using logistic regression to adjust for confounding factors.
RESULTS: Women with PCOS had a fourfold increased risk of endometrial cancer compared to women without PCOS (OR 4.0, 95% CI 1.7-9.3). This association was attenuated when additionally adjusted for body mass index (OR 2.2, 95% CI 0.9-5.7). Risk was slightly greater when restricted to Type I cancers. PCOS symptoms including hirsutism and very irregular periods were significantly associated with endometrial cancer risk.
CONCLUSIONS: These data extend existing findings, including adjustment for confounders, suggesting PCOS is a risk factor for endometrial cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20953904     DOI: 10.1007/s10552-010-9658-7

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  40 in total

1.  Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential.

Authors:  T T Piltonen; J Chen; D W Erikson; T L B Spitzer; F Barragan; J T Rabban; H Huddleston; J C Irwin; L C Giudice
Journal:  J Clin Endocrinol Metab       Date:  2013-07-03       Impact factor: 5.958

2.  Prospective study of body size throughout the life-course and the incidence of endometrial cancer among premenopausal and postmenopausal women.

Authors:  Marcelle M Dougan; Susan E Hankinson; Immaculata De Vivo; Shelley S Tworoger; Robert J Glynn; Karin B Michels
Journal:  Int J Cancer       Date:  2015-02-05       Impact factor: 7.396

Review 3.  Understanding obesity and endometrial cancer risk: opportunities for prevention.

Authors:  Rosemarie E Schmandt; David A Iglesias; Ngai Na Co; Karen H Lu
Journal:  Am J Obstet Gynecol       Date:  2011-06-07       Impact factor: 8.661

4.  PCOS and obesity: insulin resistance might be a common etiology for the development of type I endometrial carcinoma.

Authors:  Xin Li; Ruijin Shao
Journal:  Am J Cancer Res       Date:  2014-01-15       Impact factor: 6.166

Review 5.  Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Juan Pablo Domecq; Gabriela Prutsky; Rebecca J Mullan; Vishnu Sundaresh; Amy T Wang; Patricia J Erwin; Corrine Welt; David Ehrmann; Victor M Montori; Mohammad Hassan Murad
Journal:  J Clin Endocrinol Metab       Date:  2013-10-03       Impact factor: 5.958

6.  Histopathology of women with non-uniform endometrial echogenicity and risk factors for atypical endometrial hyperplasia and carcinoma.

Authors:  Qing Cong; Lingxiao Luo; Zhongpeng Fu; Jiaqi Lu; Wei Jiang; Long Sui
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

7.  YAP/TAZ regulates the insulin signaling via IRS1/2 in endometrial cancer.

Authors:  Chao Wang; Kangjin Jeong; Hongyuan Jiang; Wei Guo; Chao Gu; Yiling Lu; Jiyong Liang
Journal:  Am J Cancer Res       Date:  2016-05-01       Impact factor: 6.166

8.  Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus.

Authors:  Dylan M Glubb; Tracy A O'Mara; Pik Fang Kho; Sally Mortlock; Peter A W Rogers; Dale R Nyholt; Grant W Montgomery; Amanda B Spurdle
Journal:  Hum Genet       Date:  2021-07-15       Impact factor: 4.132

9.  DIA proteomics analysis through serum profiles reveals the significant proteins as candidate biomarkers in women with PCOS.

Authors:  Ying Yu; Panli Tan; Zhenchao Zhuang; Zhejiong Wang; Linchao Zhu; Ruyi Qiu; Huaxi Xu
Journal:  BMC Med Genomics       Date:  2021-05-09       Impact factor: 3.063

10.  Scaffold-Free Endometrial Organoids Respond to Excess Androgens Associated With Polycystic Ovarian Syndrome.

Authors:  Teerawat Wiwatpanit; Alina R Murphy; Zhenxiao Lu; Margrit Urbanek; Joanna E Burdette; Teresa K Woodruff; J Julie Kim
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.